Európska únia - slovenčina - EMA (European Medicines Agency)

otsuka pharmaceutical netherlands b.v. - tolvaptan - nevhodný syndróm adh - diuretiká, - liečba dospelých pacientov s hyponatriémiou sekundárnou k syndrómu nevhodnej sekrécie antidiuretického hormónu (siadh).

Európska únia - slovenčina - EMA (European Medicines Agency)

roche registration limited - emicizumab - hemofília a - antihemoragiká - hemlibra is indicated for routine prophylaxis of bleeding episodes in patients with haemophilia a (congenital factor viii deficiency):with factor viii inhibitorswithout factor viii inhibitors who have:severe disease (fviii < 1%)moderate disease (fviii ≥ 1% and ≤ 5%) with severe bleeding phenotype. hemlibra môžu byť použité vo všetkých vekových skupinách.

Európska únia - slovenčina - EMA (European Medicines Agency)

swedish orphan biovitrum ab - loncastuximab tesirine - lymphoma, large b-cell, diffuse; lymphoma, b-cell - antineoplastické činidlá - zynlonta as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b-cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl), after two or more lines of systemic therapy.

Európska únia - slovenčina - EMA (European Medicines Agency)

novartis europharm limited - secukinumab - arthritis, psoriatic; psoriasis; spondylitis, ankylosing - imunosupresíva - plaque psoriasiscosentyx is indicated for the treatment of moderate to severe plaque psoriasis in adults and children from the age of 6 years old who are candidates for systemic therapy. hidradenitis suppurativa (hs)cosentyx is indicated for the treatment of active moderate to severe hidradenitis suppurativa (acne inversa) in adults with an inadequate response to conventional systemic hs therapy. psoriatická arthritiscosentyx, samostatne alebo v kombinácii s metotrexátom (mtx), je indikovaná na liečbu aktívnej psoriatická artritída u dospelých pacientov, keď reakcia na predchádzajúce ochorenia úprava anti reumatických drog (dmard) terapia bola neprimeraná. axiálne spondyloarthritis (axspa)ankylozujúca spondylitída (as, radiographic axiálne spondyloarthritis)cosentyx je indikovaná na liečbu aktívnej ankylozujúcej spondylitíde u dospelých, ktorí reagovali neadekvátne konvenčná terapia. non-radiographic axial spondyloarthritis (nr-axspa)cosentyx is indicated for the treatment of active non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri) evidence in adults who have responded inadequately to non steroidal anti inflammatory drugs (nsaids). juvenile idiopathic arthritis (jia)enthesitis-related arthritis (era)cosentyx, alone or in combination with methotrexate (mtx), is indicated for the treatment of active enthesitis-related arthritis in patients 6 years and older whose disease has responded inadequately to, or who cannot tolerate, conventional therapy. juvenile psoriatic arthritis (jpsa)cosentyx, alone or in combination with methotrexate (mtx), is indicated for the treatment of active juvenile psoriatic arthritis in patients 6 years and older whose disease has responded inadequately to, or who cannot tolerate, conventional therapy.

Európska únia - slovenčina - EMA (European Medicines Agency)

eli lilly netherlands - pemetrexed - carcinoma, non-small-cell lung; mesothelioma - antineoplastické činidlá - malígny pleurálna mesotheliomapemetrexed lilly v kombinácii s cisplatin je indikovaný na liečbu chemoterapiou insitného pacientov s unresectable malígny pleurálna mesothelioma. non-small cell lung cancerpemetrexed lilly v kombinácii s cisplatin je uvedené v prvej línii liečby pacientov s lokálne pokročilým alebo metastatickým non-small cell lung cancer iné ako prevažne dlaždicových buniek histology. pemetrexed lilly je označené ako monotherapy pre udržiavaciu liečbu lokálne pokročilým alebo metastatickým non-small cell lung cancer iné ako prevažne dlaždicových buniek histology u pacientov, ktorých ochorenie nie postupoval bezprostredne po platinum-založené chemoterapia. pemetrexed lilly je označené ako monotherapy pre druhú líniu liečby pacientov s lokálne pokročilým alebo metastatickým non small cell lung cancer iné ako prevažne dlaždicových buniek histology.

Európska únia - slovenčina - EMA (European Medicines Agency)

amgen europe b.v. - panitumumab - kolorektálne novotvary - antineoplastické činidlá - vectibix is indicated for the treatment of adult patients with wild-type ras metastatic colorectal cancer (mcrc): , in first-line in combination with folfox or folfiri. v druhej línii v kombinácii s folfiri pre pacientov, ktorí dostali v prvej línii fluoropyrimidine-založené chemoterapie (s výnimkou irinotecan). ako monotherapy po poruche fluoropyrimidine-, oxaliplatin-a irinotecan-obsahujúce chemoterapia režimy.

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

curium netherlands b.v., holandsko - jodid sodný (131i) - 88 - radiopharmaca

Európska únia - slovenčina - EMA (European Medicines Agency)

jazz pharmaceuticals ireland limited - daunorubicin hydrochloride, cytarabine - leukémia, myeloidná, akútna - antineoplastické činidlá - vyxeos liposomal je indikovaný na liečbu dospelých pacientov s novo diagnostikovanou, terapie, súvisiace s akútna myeloidná leukémia (t-aml) alebo aml s myelodysplasia zmeny týkajúce sa (aml-mrk).

Európska únia - slovenčina - EMA (European Medicines Agency)

hansa biopharma ab - imlifidase - desensitization, immunologic; kidney transplantation - imunosupresíva - idefirix is indicated for desensitisation treatment of highly sensitised adult kidney transplant patients with positive crossmatch against an available deceased donor. the use of idefirix should be reserved for patients unlikely to be transplanted under the available kidney allocation system including prioritisation programmes for highly sensitised patients.

Európska únia - slovenčina - EMA (European Medicines Agency)

laboratorios farmacéuticos rovi, s.a. - risperidone - schizofrénie - psycholeptika - treatment of schizophrenia in adults for whom tolerability and effectiveness has been established with oral risperidone.